// company-profile
Climb Bio, Inc.
CLYMExchange: NasdaqSector: Pharmaceutical PreparationsInc.: DEFilings: 55Insiders: 23
// activity-summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares (net $20.0M). Buying was led by RA CAPITAL MANAGEMENT, L.P..
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | RA CAPITAL MANAGEMENT, L.P. | CLYM | Award | 2,106,000 | $9.50 | $20.01M |
| Feb 26, 2026 | Thomas Stephen Basil | CLYM | Sale | 16,313 | $7.01 | $114K |
| Feb 25, 2026 | Thomas Stephen Basil | CLYM | Sale | 33,687 | $7.00 | $236K |
| Feb 13, 2026 | Thomas Stephen Basil | CLYM | Sale | 10,000 | $5.81 | $58K |
| Feb 12, 2026 | Thomas Stephen Basil | CLYM | Sale | 90,000 | $5.23 | $471K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →